LDOC1 抗体 (N-Term)
Quick Overview for LDOC1 抗体 (N-Term) (ABIN927753)
抗原
See all LDOC1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
交叉反应
- 牛
-
纯化方法
- Purified
-
免疫原
- LDOC1 antibody was raised in rabbit using the N terminal of LDOC1 as the immunogen
-
-
-
-
应用备注
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
LDOC1 Blocking Peptide, (ABIN5614437), is also available for use as a blocking control in assays to test for specificity of this LDOC1 antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- Lot specific
-
缓冲液
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))
-
别名
- LDOC1
-
背景
- LDOC1 contains a leucine zipper-like motif and a proline-rich region that shares marked similarity with an SH3-binding domain. The protein localizes to the nucleus and is down-regulated in some cancer cell lines. It is thought to regulate the transcriptional response mediated by the nuclear factor kappa B (NF-kappaB). The gene has been proposed as a tumor suppressor gene whose protein product may have an important role in the development and/or progression of some cancers. Synonyms: Polyclonal LDOC1 antibody, Anti-LDOC1 antibody, leucine zipper, down-regulated in cancer 1 antibody, BCUR1 antibody, Mar7 antibody, Mart7 antibody.
抗原
-